A Multicenter, Randomized, Double Blind, Parallel-Group Study Comparing the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1%, to Clonidine Hydrochloride Gel Comparator in the Management of Painful Diabetic Neuropathy

Trial Profile

A Multicenter, Randomized, Double Blind, Parallel-Group Study Comparing the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1%, to Clonidine Hydrochloride Gel Comparator in the Management of Painful Diabetic Neuropathy

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Sep 2017

At a glance

  • Drugs Clonidine (Primary)
  • Indications Diabetic neuropathies
  • Focus Therapeutic Use
  • Sponsors BioDelivery Sciences International
  • Most Recent Events

    • 13 Dec 2016 Results published in the BioDelivery Sciences International Media Release
    • 13 Dec 2016 Primary endpoint has not been met. (Reduction in numerical pain rating scores (NPRS) from baseline compared to Week 12), as reported in a BioDelivery Sciences International media release.
    • 30 Nov 2016 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top